Skip to reading
British Colombia Peptides

We leave a little room around the findings.

We want research to feel easier to read. Sometimes that means explaining a result. Sometimes it means admitting the answer isn't there yet.

Five topics, each with its own space

British Colombia Peptides covers BPC-157, semaglutide, ipamorelin, NAD+ and GHK-Cu. They often appear in the same conversation, but they aren't one kind of substance with one set of answers. NAD+, for instance, isn't a peptide.

We give each topic its own island. On one page, the useful distinction is between animals and people. On another, it's a skin cream and an injection. You can choose the question that brought you here without reading everything first.

A finding can be interesting and incomplete

We keep a few useful findings close to their limits. The BPC-157 review is one example: it describes extensive animal research and very little human evidence. Both parts matter to someone reading a healing claim.

A review gathers earlier work. It doesn't add new trial participants. A small safety study can describe what happened during that study without ruling out rare harms. We explain those differences where they change how a claim reads.

Canada keeps its own question

Much of the access information here concerns the United States. We name the country when explaining its rules. An FDA statement doesn't confirm Canadian approval or permission to prescribe a product.

Our name isn't a clinic address or a service area. These pages don't arrange care or verify a way to obtain a substance in Canada. When we can't confirm a Canadian answer, we leave the gap visible.

The source is within reach

Links beside the findings take you to the paper or official page. The references page gathers them in one place, with short notes about what each helps explain. There's no need to take a broad headline on trust.

Personal stories, when discussed, are labelled as anecdotes. They can describe an experience without showing what caused it. They don't replace a comparison in people or establish how often an unwanted effect occurs.

A clearer sentence helps the next reader

The contact page explains how to flag a doubtful claim or broken link. The page address, sentence and supporting source give us something concrete to check. Personal medical details aren't needed.

This is reading help, not personal medical advice. We don't assess symptoms, prescribe or sell substances. The aim is to make a claim easier to understand, including the part the research hasn't answered.